Vivani Medical (VANI) Common Equity (2014 - 2026)
Vivani Medical (VANI) posted quarterly Common Equity of $19.1 million for Q1 2026, up 64.19% year-over-year from $11.6 million in Q1 2025, and up 21.33% quarter-over-quarter from $15.7 million in Q4 2025.
Vivani Medical (VANI) Common Equity (2014 - 2026) Analysis & Trends
Vivani Medical's Common Equity history runs 13 years deep, the most recent figure standing at $19.1 million for Q1 2026.
- In Q1 2026, Common Equity rose 64.19% year-over-year to $19.1 million; the TTM figure through Mar 2026 stood at $19.1 million (up 64.19% YoY), while the FY2025 annual figure was $15.7 million, down 10.68% from the prior year.
- Common Equity for Q1 2026 stood at $19.1 million, up from $15.7 million in the prior quarter.
- The five-year high for Common Equity was $51.4 million in Q3 2022, with the low at -$4.8 million in Q2 2022.
- The 5-year median for Common Equity is $19.1 million (2026), against an average of $20.5 million.
- The sharpest annual moves came in 2022 and 2023: Common Equity tumbled 444.49% in 2022, then jumped 3531.84% in 2023.
- Vivani Medical's Common Equity stood at $44.3 million in 2022, then plunged by 53.14% to $20.8 million in 2023, then fell by 15.18% to $17.6 million in 2024, then decreased by 10.68% to $15.7 million in 2025, then rose by 21.33% to $19.1 million in 2026.
- Business Quant data shows VANI's Common Equity at $19.1 million in Q1 2026, $15.7 million in Q4 2025, and $1.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 20.25 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 31.71 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 6.76 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 5.17 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 1.35 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 22.38 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 757.49 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 9.79 Bn |
| 10 | Vivani Medical | 120.18 Mn | 100.29 Mn | - | 18.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 18.97 Mn |
| Mar 31, 2026 | 19.09 Mn |
| Dec 31, 2025 | 15.73 Mn |
| Sep 30, 2025 | 1.31 Mn |
| Jun 30, 2025 | 4.91 Mn |
| Mar 31, 2025 | 11.62 Mn |
| Dec 31, 2024 | 17.61 Mn |
| Sep 30, 2024 | 18.33 Mn |
| Jun 30, 2024 | 23.82 Mn |
| Mar 31, 2024 | 28.71 Mn |
| Dec 31, 2023 | 20.76 Mn |
| Sep 30, 2023 | 26.21 Mn |
| Jun 30, 2023 | 32.39 Mn |
| Mar 31, 2023 | 38.37 Mn |
| Dec 31, 2022 | 44.31 Mn |
| Sep 30, 2022 | 51.36 Mn |
| Jun 30, 2022 | -4.82 Mn |
| Mar 31, 2022 | -1.12 Mn |
| Dec 31, 2021 | 2.47 Mn |
| Sep 30, 2021 | 1.43 Mn |